Hi there!
We track 52,000+ AI startups and surface hidden job opportunities that never appear on LinkedIn. Tell us what you're looking for, our AI agent does the searching. It's free and you sign up using Google. Go explore!
Immunai
Comprehensively mapping and decoding the immune system with single-cell biology and AI to power new therapeutic discoveries, accelerate drug development and improve patient outcomes
Immunai
Comprehensively mapping and decoding the immune system with single-cell biology and AI to power new therapeutic discoveries, accelerate drug development and improve patient outcomes
TL;DR
Mission: Map and decode the human immune system using single-cell and multi‑omic biology plus machine learning
Core product: AMICA — Annotated Multi‑omic Immune Cell Atlas
Founded: December 2018
Headcount (approx.): 183 employees
Total funding: USD 295,000,000
Company Overview
Problem Domain
Immune system mapping for drug discovery, biomarker development, and immune‑response prediction
Founded
2018
Industry
Biotechnology Research
Funding Track Record
USD 20,000,000
Reported seed financing
USD 60,000,000
Reported Series A
USD 215,000,000
Investor Signal
“Koch Disruptive Technologies led the Series B with participation from multiple VC and strategic investors”
Founders
What we do
Join the Team
Startup jobs. A lot of them.
Your next opportunity is in here somewhere. Sign up to explore 52,000+ startups and their open roles. No spam. No gamification. Just jobs.
52,000+
Startups
66,000+
Open Roles
1,500+
New This Week
Related Companies
| Company |
|---|
 |
 |
 |
 |
 |